Extended
Hospital Stay
Dysphagia Therapy Like No Other
Robust Evidence
Favorable Economics
Seamless Integration
Dysphagia is Common, Costly, and Harmful to Patients
Treating the Root Cause of Dysphagia.
Introducing the first and only treatment using Pharyngeal Electrical Stimulation (PES) to restore swallowing control, facilitate airway protection, and accelerate recovery.
Personalized levels of PES, delivered at the earliest stages after injury, enhance neurorehabilitation and reorganization of swallowing control, while requiring minimal patient participation.

Patient-Tailored Stimulation
Measures Individual Sensory Capacity
Dual-Function Catheter
Feeding Delivery + Stimulation Delivery
Simple & Safe

Adjust the catheter to reflect patient anatomy and then insert. When ready to deliver treatment, connect the catheter to the Base Station.

Follow Base Station on-screen instructions to measure patient sensory capacity and optimize the stimulation level.

Deliver optimized stimulation for 10 minutes once per day. On completion, disconnect the Base Station. Leave the catheter in place.

Repeat for 3-6 days as clinically indicated. On completion of the treatment regimen, remove the catheter or leave in place for feeding for up to 30 days.
Extensive Clinical Evidence
Control Trials
Phagenesis Appoints Chad Hoskins as Chief Executive Officer Following Recent Close of $42M Series D Financing
MANCHESTER, England, Sept. 5, 2024 /PRNewswire/ — Phagenesis, a pioneering company that has developed a first-of-its-kind neurostimulation system to treat swallowing dysfunction, today announced the appointment of Chad Hoskins as Chief Executive Officer (CEO). The seasoned executive brings decades of experience in scaling innovative MedTech therapies, driving commercial growth in the US and delivering on strategic objectives. “We are extremely excited to have Chad join the company at this critical phase of growth as we build on our success in Europe and expand the use of Phagenyx® in the US,” said Oern Stuge, MD, Chairman of the Board of Directors, Phagenesis. “His relentless focus on improving patient care…